COVID-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval
Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday. Ciara Lee reports.
UP NEXT
UP NEXT
-
U.S. Capitol lockdown lifted, fire nearby contained
Reuters
-
Vaccine nationalism puts world on brink of 'catastrophic moral failure' - WHO chief
Reuters
-
Detained Kremlin foe Navalny rushed to court, Moscow tells West to butt out
Reuters
-
"Are you detaining me?" Navalny flies home, and straight into trouble
Reuters
-
Ugandan opposition party says it will challenge election result; two dead in protests
Reuters
-
Uganda's Museveni heads for election win, rival alleges fraud
Reuters
-
Sanitation worker gets first shot as India launches COVID-19 vaccination campaign
Reuters
-
U.S. health secretary Azar resigns, cites Capitol attack - CNN
Reuters
-
Vaccine shortages arise across U.S., halting inoculations in some places
Reuters
-
Exclusive: International COVID-19 vaccine poll shows higher mistrust of Russia, China shots
Reuters
-
Retired doctors and more syringes: Biden lays out plan to get America vaccinated
Reuters
-
Pence vows to honor U.S. history, ensure safe inauguration of new president
Reuters
-
Indonesia quake kills at least 35, injures hundreds
Reuters
-
Judge orders detention of man accused of hurling fire extinguisher at Capitol Police
Reuters
-
Italy's Conte looks for outside backing after Renzi quits government
Reuters
-
Canada, allies expect Biden to re-engage U.S. on world stage, Trudeau says
Reuters